Christi Shaw

Insider Reports History

Location
Indianapolis, IN
Signature
By: /s/ Samantha Eldredge, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christi Shaw:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avantor, Inc. Director Common Stock 36,271 $828,067 $22.83 11 May 2023 Direct
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 33,662 $563,982 $24.40 04 Jun 2025 Direct
Kyverna Therapeutics, Inc. Executive Chairperson, Director Common Stock 70,935 $561,095 $7.91 12 Jan 2026 Direct
Kyverna Therapeutics, Inc. Executive Chairperson, Director Stock Option (right to buy) 185,000 12 Jan 2026 Direct

Insider Reports Filed by Christi Shaw

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYTX Kyverna Therapeutics, Inc. 12 Jan 2026 3 $0 4 Executive Chairperson, Director 14 Jan 2026, 17:00
BEAM Beam Therapeutics Inc. 04 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
KYTX Kyverna Therapeutics, Inc. 29 May 2025 2 $0 4 Director 02 Jun 2025, 18:40
KYTX Kyverna Therapeutics, Inc. 14 Feb 2025 1 $0 4 Director 19 Feb 2025, 17:55
KYTX Kyverna Therapeutics, Inc. 16 Sep 2024 1 $0 4 Director 18 Sep 2024, 21:16
KYTX Kyverna Therapeutics, Inc. 16 Sep 2024 0 $0 3 Director 18 Sep 2024, 21:11
BEAM Beam Therapeutics Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:48
BEAM Beam Therapeutics Inc. 13 Dec 2023 1 $0 4 Director 14 Dec 2023, 16:15
BEAM Beam Therapeutics Inc. 13 Dec 2023 0 $0 3 Director 14 Dec 2023, 16:10
AVTR Avantor, Inc. 11 May 2023 1 $0 4 Director 15 May 2023, 16:44
AVTR Avantor, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 18:16
AVTR Avantor, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 16:59